Sartorius AG

Sartorius AG
Company type	Aktiengesellschaft
Traded as	FWB: SRT; FWB: SRT3; FWB: SRT0 (ADR); FWB: SRT4 (ADR); Euronext Paris: DIM; OTC Pink Current: SARTF; OTC Pink Current: SUVPF; OTC Pink Limited: SSSGY (ADR); OTC Pink Limited: SOAGY (ADR); LSE: 0NIQ; LSE: 0NIR; DAX component (SRT3); CAC Next 20 component (DIM);
ISIN	DE0007165607; DE0007165631; FR0013154002; US80385Q2084; US80385Q1094;
Industry	Pharmaceutical and Laboratory Equipment
Founded	1870; Göttingen, Germany
Founder	Florenz Sartorius
Headquarters	Göttingen, Germany
Area served	Worldwide
Key people	Joachim Kreuzburg (CEO & Executive Board Chair); René Fáber (Executive Board Member); Alexandra Gatzemeyer (Executive Board Member); Florian Funck (CFO);
Revenue	€3.4 billion (2024)
Number of employees	13,528 (2024)

Sartorius AG is an international pharmaceutical and laboratory equipment supplier. In September 2021, Sartorius was admitted to the DAX, Germany's largest stock market index. Sartorius supports its customers in the development and production of biotech drugs and vaccines. The company has two major divisions: Bioprocess Solutions and Lab Products & Services.